2016
DOI: 10.1016/j.maturitas.2016.02.001
|View full text |Cite
|
Sign up to set email alerts
|

Clinical challenges in thyroid disease: Time for a new approach?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2017
2017
2018
2018

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 30 publications
0
3
0
Order By: Relevance
“…Such mechanisms may be at the basis of CFS symptoms and may explain the lower urinary iodine excretion in CFS patients as compared with controls, although the latter also exhibited a relatively high prevalence of low iodine excretion (Table 1 ). Intracellular D3-catalyzed liberation of iodide from T4 and T3 may serve various antioxidant and defense functions that may potentially contribute to high intracellular “thyroid hormone consumption,” manifesting as the “low T3 syndrome” with negative iodine balance in the long term ( 67 , 83 , 97 ).…”
Section: Discussionmentioning
confidence: 99%
“…Such mechanisms may be at the basis of CFS symptoms and may explain the lower urinary iodine excretion in CFS patients as compared with controls, although the latter also exhibited a relatively high prevalence of low iodine excretion (Table 1 ). Intracellular D3-catalyzed liberation of iodide from T4 and T3 may serve various antioxidant and defense functions that may potentially contribute to high intracellular “thyroid hormone consumption,” manifesting as the “low T3 syndrome” with negative iodine balance in the long term ( 67 , 83 , 97 ).…”
Section: Discussionmentioning
confidence: 99%
“…Iodine defi ciency is the most common cause of hypothyroidism worldwide, however, autoimmune thyroiditis is the most common cause in regions with enough iodine in the diet [3]. Radioactive iodine treatment, total or subtotal thyroidectomy are other causes in hypothyroidism etiology [4]. Levothyroxine sodium (LT4) alone or combined with liothyronine protocols are given to maintain euthyroid state [5].…”
Section: Introductionmentioning
confidence: 99%
“…Levothyroxine sodium (LT4) alone or combined with liothyronine protocols are given to maintain euthyroid state [5]. Thyroid-stimulating hormone (TSH) levels are monitored to help determine whether the dose is adequate within 4-6 weeks period, follow-up must continue until to maintain euthyroid hormone levels [4]. Treatment goals in healthy young population are to achieve optimal TSH levels under 4 mIU/L [6].…”
Section: Introductionmentioning
confidence: 99%